The Impact of Ejection Fraction on Major Adverse Limb Events after Lower Extremity Revascularization

被引:1
|
作者
Jamil, Yasser [1 ]
Huttler, Joshua [2 ]
Alameddine, Dana [3 ]
Wu, Zhen [4 ]
Zhuo, Haoran [4 ]
Mena-Hurtado, Carlos [5 ]
Velazquez, Eric J. [5 ]
Guzman, Raul J. [3 ]
Chaar, Cassius Iyad Ochoa [3 ]
机构
[1] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[2] Yale Sch Med, New Haven, CT USA
[3] Yale Sch Med, Dept Surg, Div Vasc Surg & Endovasc Therapy, New Haven, CT USA
[4] Yale Sch Publ Hlth, New Haven, CT USA
[5] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA
关键词
PERIPHERAL ARTERIAL-DISEASE; HEART-FAILURE; ENDOVASCULAR INTERVENTION; OUTCOMES; RISK; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; MORTALITY;
D O I
10.1016/j.avsg.2023.08.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Peripheral arterial disease (PAD) is commonly associated with coronary artery disease, and echocardiography is frequently performed before lower extremity revascularization (LER). However, the incidence of various echocardiographic findings in patients with PAD and their impact on the outcomes of LER has not been well studied. Reduced ejection fraction (EF) <= 40% is associated with increased major adverse limb events (MALE) after LER.Methods: The electronic medical records of patients undergoing LER in a single center were reviewed. Patients were divided based on the presence or absence of reduced EF. Patient, transthoracic echocardiogram, procedural characteristics, and outcomes were compared be-tween the 2 groups.Results: A total of 1,114 patients (N = 131, 11.8% with reduced EF) underwent LER between 2013 and 2019. Patients with reduced EF were more likely to be male and have a history of coronary artery disease and heart failure. Furthermore, they were more likely to have diastolic dysfunction with moderate to severe mitral and tricuspid valve regurgitation. Patients with reduced EF were more likely to undergo LER for chronic limb-threatening ischemia, and to be treated with endovascular procedures. Perioperatively, patients with reduced EF were more likely to develop myocardial infarction. Lastly, the 2 groups had no difference in overall MALE or major amputation. However, on KaplaneMeier curves, MALE-free survival was significantly lower for patients with reduced EF. Regression analysis demonstrated that indication and not EF was associated with MALE and MALE-free survival.Conclusions: Reduced EF is associated with decreased MALE-free survival for patients with PAD undergoing LER.
引用
收藏
页码:210 / 219
页数:10
相关论文
共 50 条
  • [31] Preoperative Statins and Limb Salvage After Lower Extremity Revascularization in the Medicare Population
    Vogel, Todd R.
    Dombrovskiy, Viktor Y.
    Galinanes, Edgar Luis
    Kruse, Robin L.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (06) : 694 - 700
  • [32] Limb loss after lower extremity revascularization in patients with renal insufficiency.
    O'Hare, AM
    Sidawy, AN
    Feinglass, J
    Merine, KM
    Daley, J
    Khuri, S
    Henderson, WG
    Johansen, KL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 263A - 264A
  • [33] Hemoglobin A1c Levels Impact Patency and Adverse Limb Events in Diabetics After Revascularization
    Repasky, Amber
    Nader, Nader
    Rivero, Mariel
    Montross, Brittany
    Dosluoglu, Hasan
    JOURNAL OF VASCULAR SURGERY, 2022, 76 (03) : E25 - E26
  • [35] Association Between Wearable Device-Based Measures of Physical Frailty and Major Adverse Events Following Lower Extremity Revascularization
    Najafi, Bijan
    Veranyan, Narek
    Zulbaran-Rojas, Alejandro
    Park, Catherine
    Nguyen, Hung
    Nakahara, Quinn Kaleikaumaka
    Elizondo-Adamchik, Hector
    Chung, Jayer
    Mills, Joseph L.
    Montero-Baker, Miguel
    Armstrong, David G.
    Rowe, Vincent
    JAMA NETWORK OPEN, 2020, 3 (11)
  • [36] Regarding "Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention"
    Krzanowski, Marek
    Partyka, Lukasz
    JOURNAL OF VASCULAR SURGERY, 2018, 67 (05) : 1637 - 1637
  • [37] C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization
    Stone, Patrick A.
    Schlarb, Haley
    Campbell, John E.
    Williams, David
    Thompson, Stephanie N.
    John, Molly
    Campbell, James R.
    AbuRahma, Ali F.
    JOURNAL OF VASCULAR SURGERY, 2014, 60 (03) : 652 - 659
  • [38] Occurrence of Major Local Lower Limb Events in Type 2 Diabetic Patients with Lower Extremity Arterial Disease: Impact of Metformin
    Tan, Shanon
    Goudot, Guillaume
    Arnoux, Armelle
    Tran, Yohann
    Maissoro, Hassan
    Poenou, Geraldine
    Detriche, Gregoire
    Khider, Lina
    Mohamedi, Nassim
    Mirault, Tristan
    Galloula, Alexandre
    Messas, Emmanuel
    ANNALS OF VASCULAR SURGERY, 2023, 90 : 153 - 161
  • [39] Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis
    Iwai, Takamasa
    Yamaguchi, Tetsuo
    Ueshima, Daisuke
    Tobita, Kazuki
    Mizuno, Atsushi
    Fujimoto, Yo
    Miyazaki, Ryoichi
    Shimura, Tsukasa
    Goto, Ryo
    Murata, Naotaka
    Anzai, Hitoshi
    Higashitani, Michiaki
    HEART AND VESSELS, 2023, 38 (04) : 488 - 496
  • [40] Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis
    Takamasa Iwai
    Tetsuo Yamaguchi
    Daisuke Ueshima
    Kazuki Tobita
    Atsushi Mizuno
    Yo Fujimoto
    Ryoichi Miyazaki
    Tsukasa Shimura
    Ryo Goto
    Naotaka Murata
    Hitoshi Anzai
    Michiaki Higashitani
    Heart and Vessels, 2023, 38 : 488 - 496